Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.

Hanger DP, Seereeram A, Noble W.

Expert Rev Neurother. 2009 Nov;9(11):1647-66. doi: 10.1586/ern.09.104. Review.

PMID:
19903024
2.

Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

Gong CX, Grundke-Iqbal I, Iqbal K.

Neuroscience. 1994 Aug;61(4):765-72.

PMID:
7838376
3.

Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.

Iqbal K, Grundke-Iqbal I.

Mol Neurobiol. 1991;5(2-4):399-410. Review.

PMID:
1726645
4.

The role of tau in Alzheimer's disease and related disorders.

Medeiros R, Baglietto-Vargas D, LaFerla FM.

CNS Neurosci Ther. 2011 Oct;17(5):514-24. doi: 10.1111/j.1755-5949.2010.00177.x. Epub 2010 Jun 14. Review.

5.

The role of tau phosphorylation in the pathogenesis of Alzheimer's disease.

Mi K, Johnson GV.

Curr Alzheimer Res. 2006 Dec;3(5):449-63. Review.

PMID:
17168644
6.

Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis.

Rametti A, Esclaire F, Yardin C, Terro F.

J Biol Chem. 2004 Dec 24;279(52):54518-28. Epub 2004 Oct 8.

7.

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.

Kumar P, Jha NK, Jha SK, Ramani K, Ambasta RK.

J Alzheimers Dis. 2015;43(2):341-61. doi: 10.3233/JAD-140933. Review.

PMID:
25096626
8.

Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.

Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S.

Neuropathol Appl Neurobiol. 2014 Feb;40(2):121-35. doi: 10.1111/nan.12084.

PMID:
24033439
9.

Tau phosphorylation and aggregation in Alzheimer's disease pathology.

Avila J.

FEBS Lett. 2006 May 22;580(12):2922-7. Epub 2006 Mar 3. Review.

10.

Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin).

Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K.

J Neurochem. 1994 Feb;62(2):803-6.

PMID:
8294942
11.

Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.

An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B, Pei JJ.

Am J Pathol. 2003 Aug;163(2):591-607. Erratum in: Am J Pathol. 2003 Dec;163(6):2645.

12.

GSK3: a possible link between beta amyloid peptide and tau protein.

Hernández F, Gómez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J.

Exp Neurol. 2010 Jun;223(2):322-5. doi: 10.1016/j.expneurol.2009.09.011. Epub 2009 Sep 24. Review.

PMID:
19782073
13.

Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.

Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Terro F.

Ageing Res Rev. 2013 Jan;12(1):39-49. doi: 10.1016/j.arr.2012.06.008. Epub 2012 Jul 6. Review.

PMID:
22771380
14.
15.

Disruption of the cytoskeleton in Alzheimer's disease.

Lee VM.

Curr Opin Neurobiol. 1995 Oct;5(5):663-8. Review.

PMID:
8580719
16.

Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.

Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K.

J Alzheimers Dis. 2013;33 Suppl 1:S123-39. Review.

PMID:
22710920
17.

Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau.

Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM.

Neuron. 1994 Oct;13(4):989-1002.

PMID:
7946342
19.

The role of tau kinases in Alzheimer's disease.

Dolan PJ, Johnson GV.

Curr Opin Drug Discov Devel. 2010 Sep;13(5):595-603. Review.

20.

Tau aggregation in Alzheimer's disease: what role for phosphorylation?

Lippens G, Sillen A, Landrieu I, Amniai L, Sibille N, Barbier P, Leroy A, Hanoulle X, Wieruszeski JM.

Prion. 2007 Jan-Mar;1(1):21-5. Epub 2007 Jan 23. Review.

Supplemental Content

Support Center